Literature DB >> 6375920

Elevated beta 2-microglobulin and lysozyme levels in patients with acquired immune deficiency syndrome.

M H Grieco, M M Reddy, H B Kothari, M Lange, E Buimovici-Klein, D William.   

Abstract

beta 2-Microglobulin (beta 2-M) levels in sera and urines, and lysozyme levels in sera, were quantitated in healthy heterosexual men and several groups of homosexual males. The mean beta 2-M levels in sera and urines and lysozyme levels in sera of healthy heterosexual and homosexual men were not significantly different. However, beta 2-M levels in patients with lymphadenopathy syndrome and AIDS were elevated. The mean beta 2-M level in sera of 11 patients with the lymphadenopathy syndrome was 4016 +/- 473 micrograms/l (SEM) (P less than 0.001) and 5409 +/- 462 micrograms/l (P less than 0.001) in 27 patients with AIDS. Similarly, beta 2-M levels in the urines of patients with chronic diarrheal syndrome, lymphadenopathy syndrome, and those meeting the CDC surveillance definition of AIDS were also significantly elevated (P less than 0.025). The mean lysozyme levels in the sera of 11 patients with the lymphadenopathy syndrome was 16.58 +/- 0.04 microgram/ml, and in 27 patients with AIDS 15.40 +/- 1.16 microgram/ml, compared to the mean level obtained in normal heterosexual men of 6.67 +/- 0.42 microgram/ml (P less than 0.001). The results of this study suggest that measuring beta 2-M in serum and urine and lysozyme levels in serum might provide additional useful parameters for the evaluation of patients with AIDS and prodromal syndromes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375920     DOI: 10.1016/0090-1229(84)90119-3

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  12 in total

1.  Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis.

Authors:  K A Near; M J Lefford
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  BETA-2-MICROGLOBULIN LEVELS IN HUMAN-IMMUNODEFICIENCY VIRUS INFECTED SUBJECTS.

Authors:  Mkk Rao; S K Sayal; S S Uppal; R M Gupta; V C Ohri; S Banerjee
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?

Authors:  M M Chan; J M Campos; S Josephs; N Rifai
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

4.  [HIV-1 antigenemia and T-cell activation in HIV-1 infected patients].

Authors:  T Harrer; B Wolf; W Kersten; W Schwarz; D Bergner; J R Kalden
Journal:  Klin Wochenschr       Date:  1990-09-03

Review 5.  Recent advances in the medical management of early HIV disease.

Authors:  P A Volberding
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

6.  Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.

Authors:  M M Reddy; M Lange; M H Grieco
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

7.  [Follow-up in HIV-infected homosexual males with lymphadenopathy syndrome].

Authors:  T Harrer; K Messing; U Bienzle; E Meyer; J Giedl; J R Kalden
Journal:  Klin Wochenschr       Date:  1987-09-15

8.  Human immunodeficiency virus infection of monoblastoid cells: cellular differentiation determines the pattern of virus replication.

Authors:  C D Pauza; J Galindo; D D Richman
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

9.  Elevated levels of CD4 antigen in sera of human immunodeficiency virus-infected populations.

Authors:  M M Reddy; M Vodian; M H Grieco
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

Review 10.  Markers predicting progression of human immunodeficiency virus-related disease.

Authors:  C M Tsoukas; N F Bernard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.